Momelotinib
Drug timelines are a Plus or Pro feature.
20 regulatory and trial events tracked for Momelotinib, covering 2018-05-09 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome [Phase 2]